How can you sleep during a solo sailing race?

Bologna (June 4, 2020) — You are alone on a small sailing boat, more than four thousand miles of ocean ahead and you are up against approximately 80 sailors. It will take you three or four weeks to get to the finishing line. But how will you manage to sleep and which sleeping strategy will pay off during the race? For the first time, a group of researchers of the University of Bologna identified and analysed the different sleeping strategies employed by solo skippers.

“Especially during singlehanded transatlantic races, sailing needs a skipper that is ready to intervene rapidly and with soundness of mind in full control of his body and brain. This is the only way to be able to quickly modify the yacht route and attitude”, explains Giuseppe Plazzi, study coordinator and Unibo professor. “Moreover, sailors are forced to be vigil for long periods of time as they need to face unstable and adverse weather conditions. Appropriate sleep management even before the race can be a decisive factor in their sailing performance and safety”.

A number of sleep management strategies emerge from this study published in Nature and Science of Sleep. Some sailors stock up on sleep before the race, some others prefer short and frequent naps, while some other skippers get used to increasingly shorter sleeping periods. The study also brings to the fore a “natural selection” among sailors, one that favours early birds (who wake up early in the morning and are more active in the first hours of the day) and excludes night owls (who instead are more active during the evening and night). These results could be useful in preparing athletes for endurance competitions.


FROM FRANCE TO THE CARIBBEAN

To study sailors’ sleep management, the researchers focused on the participants in the Mini Transat La Boulangère, one of the most crowded solo regattas. On odd-numbered years, more than 80 sailors race across the Atlantic Ocean for 4,050 miles and live aboard 6 meters boats. The race presents two stops. The boats set sail from France west coast, La Rochelle, then after 1,350 miles they stop at the Canary Islands. From there, they cross the Atlantic for 2,700 miles and, thanks to the trade winds, they reach Martinique, an island in the Caribbean.

Researchers analysed a sample of 42 skippers, gathering data and information about the training weeks preceding the regatta. They asked the skippers about the quality of their sleep, their level of somnolence and their chronotype, i.e. the propensity for the individual to sleep at a particular time during a 24-hour period.


SLEEP MANAGEMENT STRATEGIES

The analysis reveals that more than half of the skippers in the sample (55%) choose to prep for the regatta by devising a sleep management strategy. “Expert skippers often make this choice”, says professor Plazzi. “Indeed, expert sailors with a track record of miles and miles of offshore sailing are more mindful of the importance of sleep management”.

Which strategies do they employ? The most frequent strategy (52%) is sleep extension, that is stoking up on sleep before the race so to have a sort of “sleep storage” available during the competition when sleep time and quality inevitably decrease. 26% of the skippers adopted polyphasic sleep. In polyphasic sleep, a nap schedule has to be followed throughout the day. This strategy allows to be more vigil and to be absent from the rudder for limited periods of time. Finally, 22% of the sample opted for gradual sleep deprivation in order to strike a balance between a short period of restorative sleep and the psycho-physical conditions to get the race done.


SKIPPERS ARE NOT “NIGHT OWLS”

Chronotype is another interesting matter here. It represents propensity for being more active at a particular time of the day, thus influencing sleep and wake periods. In this case, researchers observed a “natural selection” among the skippers of the Mini Transat La Boulangère. 40% of the sample presents the morning-type profile. These skippers can be defined as “early birds”: they wake up early, are more active in the morning and go to sleep early. 60% of the skippers in the sample belongs instead to an intermediate chronotype, the so-called “hummingbird”: they do not show a preponderant preference towards being active in the morning or at night. No one in the sample displayed the third chronotype (eveningness or “night owls”), according to which a person tends to go to bed late and wake up late in the morning.

“In our sample, the morning-type chronotype is definitely overrepresented: ‘early birds’ represent 25% of the general population”, explains Plazzi. “Even more surprising is the fact that there aren’t any ‘night owls’ in our sample. This means that ‘eveningness’ represents a disadvantage in endurance competitions”.


CHRONOTYPE AND STRATEGIES

Sleeping management strategies and chronotype also intertwine. A striking majority of the skippers adopting sleeping management strategies belongs to the intermediate-type profile, while those who do not follow sleeping schedules belong to the morning type. According to the researchers, this result can hint at a lack of flexibility among the “early birds”. Indeed, it would seem more difficult for them to radically change their sleep-wake cycles.

“The results of our study clearly show the importance of choosing a sleeping management strategy during the psycho-physical preparation for extreme competitions such as single-handed transatlantic crossings”, concludes Professor Plazzi. “Our next step will be to closely monitor sleep-wake cycles both during the training and during the race. In this way, we will be able to devise increasingly effective and precise sleep management strategies”.


THE AUTHORS OF THE STUDY

The study was published on the journal Nature and Science of Sleep with the title “Pre-Race Sleep Management Strategy and Chronotype of Offshore Solo Sailors”. The authors of the paper are Marco Filardi, Silvia Morini and Giuseppe Plazzi from the Department of Biomedical and Neuromotor Sciences at the University of Bologna.

 


Università di Bologna, 04.06.2020 (tB).

MEDICAL NEWS

About half of health care workers positive for COVID-19 by…
Teva presents latest data on AJOVY® ▼ (fremanezumab) at EHF…
How fear transforms into anxiety
The best (and worst) materials for mask
Therapy delivered electronically more effective than face to face

SCHMERZ PAINCARE

Deutsche Gesellschaft für Schmerzmedizin fordert Anerkennung von Nicht-Psychologen in der…
DBfK: Besondere Rolle für Pflegeexpert/innen Schmerz – nicht nur in…
Vagus-Stimulation: Neuartige Strom-Impulse lindern Schmerz
Aktuelle Aspekte der Anwendung von Cannabinoiden in Schmerz- und Palliativmedizin:…
Deutsche Gesellschaft für Neurologie (DGN): Ingwerextrakt hilft nicht zur Prophylaxe…

DIABETES

“Körperstolz”: Michael Krauser managt seinen Diabetes digital
Der richtige Sensor – von Anfang an
Diabetes mellitus: Ein Risikofaktor für frühe Darmkrebserkrankungen
Fastenmonat Ramadan: Alte und neue Herausforderung für chronisch Erkrankte während…
Sanofi setzt sich für die Bedürfnisse von Menschen mit Diabetes…

ERNÄHRUNG

Corona-Erkrankung: Fehl- und Mangelernährung sind unterschätze Risikofaktoren
Gesundheitliche Auswirkungen des Salzkonsums bleiben unklar: Weder der Nutzen noch…
Robert Koch-Institut: Fast Food, Bio-Lebensmittel, Energydrinks – Journal of Health…
Neue Daten zur Ernährungssituation in deutschen Krankenhäusern und Pflegeheimen: Mangelernährung…
Baxter: Parenterale Ernährung von Patienten mit hohem Aminosäurenbedarf

ONKOLOGIE

Finanzierung der ambulanten Krebsberatung weiterhin nicht gesichert
Lungenkrebsscreening mittels Low-Dose-CT: Anhaltspunkt für einen Nutzen
Eisenmangel/-anämie bei Tumorpatienten: Frühzeitige Diagnose und Therapie sind entscheidend
Gentest zur Vorbeugung von Chemotherapie-Nebenwirkungen. Alte Substanzen vor neuen Herausforderungen
Fortbildung für Pflegende zum „OncoCoach“

MULTIPLE SKLEROSE

Multiple Sklerose: Novartis’ Siponimod verzögert Krankheitsprogression und Hirnatrophie bei aktiver…
Neurofilamente als Diagnose- und Prognosemarker für Multiple Sklerose
Bedeutung der Langzeittherapie bei Multipler Sklerose – mehr Sicherheit und…
Bristol Myers Squibb erhält Zulassung der Europäischen Kommission für Ozanimod…
Einige MS-Medikamente könnten vor SARS-CoV-2/COVID-19 schützen

PARKINSON

Neue Studie zur tiefen Hirnstimulation bei Parkinson-Erkrankung als Meilenstein der…
Parkinson-Patienten in der Coronakrise: Versorgungssituation und ein neuer Ratgeber
Neuer Test: Frühzeitige Differenzialdiagose der Parkinson-Erkrankung
Gegen das Zittern: Parkinson- und essentiellen Tremor mit Ultraschall behandeln…
Projekt VAFES: Expertenteam entwickelt Diagnosesystem für Parkinson-Patienten